“According to a new report published by Introspective Market Research, Pulmonary Function Testing Systems Market by Product Type, Test Type, and End User, The Global Pulmonary Function Testing Systems Market Size Was Valued at USD 153.16 Million in 2024 and is Projected to Reach USD 357.48 Million by 2035, Growing at a CAGR of 8.01% from 2025–2035.”

Pulmonary Function Testing (PFT) Systems are medical diagnostic devices used to evaluate lung function and respiratory health. These systems measure parameters such as lung volume, airflow, and gas exchange efficiency, enabling clinicians to diagnose, monitor, and manage respiratory disorders including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and other lung-related conditions.

Compared to traditional diagnostic methods, modern pulmonary function testing systems offer higher accuracy, faster test execution, digital data integration, and improved patient comfort. The increasing adoption of computerized spirometry, body plethysmography, and diffusion testing has enhanced clinical decision-making and workflow efficiency across healthcare settings.

The market is witnessing steady growth due to the rising prevalence of respiratory diseases, growing geriatric population, increasing air pollution levels, and expanding awareness regarding early diagnosis of pulmonary disorders. Technological advancements and rising healthcare investments across both developed and emerging economies continue to strengthen the global pulmonary function testing systems market outlook.

Market Segmentation

The Pulmonary Function Testing Systems Market is segmented into Product Type, Test Type, and End User. By Product Type, the market is categorized into Spirometers, Gas Analyzers, Body Plethysmographs, Peak Flow Meters, and Others. By Test Type, the market is categorized into Spirometry, Lung Volume Tests, Diffusion Capacity Tests, and Others. By End User, the market is categorized into Hospitals, Diagnostic Laboratories, Specialty Clinics, and Home Care Settings.

Growth Driver

The rising prevalence of chronic respiratory diseases is a major driver of the pulmonary function testing systems market. Conditions such as asthma and COPD are increasing globally due to factors including smoking, occupational exposure, aging populations, and worsening air quality. As early diagnosis and continuous monitoring become critical in managing these conditions, healthcare providers are increasingly adopting pulmonary function testing systems. Additionally, government initiatives promoting respiratory health screening and increasing healthcare expenditure are accelerating the adoption of advanced diagnostic technologies, further fueling market growth during the forecast period.

Market Opportunity

Technological advancements in portable and home-based pulmonary function testing systems present significant growth opportunities for market players. The increasing demand for remote patient monitoring and home healthcare solutions is driving the development of compact, user-friendly, and wireless PFT devices. Integration of digital platforms, cloud-based data storage, and AI-driven analytics enables real-time monitoring and improved disease management. Emerging economies with expanding healthcare infrastructure and rising awareness of respiratory health also offer untapped opportunities for manufacturers to expand their global footprint.

Detailed Segmentation

Pulmonary Function Testing Systems Market, Segmentation

The Pulmonary Function Testing Systems Market is segmented on the basis of Product Type, Test Type, and End User.

Product Type

The Product Type segment is further classified into Spirometers, Gas Analyzers, and Body Plethysmographs. Among these, the Spirometers sub-segment accounted for the highest market share in 2024. Spirometers are widely used due to their cost-effectiveness, ease of use, and ability to provide rapid lung function assessment. They are commonly deployed in hospitals, clinics, and diagnostic centers for routine screening and disease monitoring, making them the most adopted pulmonary testing devices globally.

Test Type

The Test Type segment is further classified into Spirometry, Lung Volume Tests, and Diffusion Capacity Tests. Among these, the Spirometry sub-segment accounted for the highest market share in 2024. Spirometry is the most commonly performed pulmonary function test due to its diagnostic reliability, non-invasive nature, and suitability for large-scale screening. It plays a critical role in diagnosing asthma and COPD, supporting its widespread clinical adoption.

Some of The Leading/Active Market Players Are

• Medtronic (Ireland)
• Philips Healthcare (Netherlands)
• GE HealthCare (U.S.)
• MGC Diagnostics Corporation (U.S.)
• SCHILLER AG (Switzerland)
• Vyaire Medical (U.S.)
• ndd Medical Technologies (Switzerland)
• COSMED (Italy)
• Vitalograph (Ireland)
• Fukuda Denshi Co., Ltd. (Japan)
• Hillrom Holdings, Inc. (U.S.)
• CareFusion Corporation (U.S.)
• Medical International Research (Italy)
• KoKo PFT (U.S.)
• Chest M.I., Inc. (Japan)
and other active players.

Key Industry Developments

In March 2024, a leading medical device manufacturer launched an advanced portable spirometry system designed for home-based respiratory monitoring.
The device integrates wireless connectivity and cloud-based data sharing, enabling clinicians to remotely track patient lung function and improve chronic disease management outcomes.

In September 2023, a global healthcare company expanded its pulmonary diagnostics portfolio through a strategic acquisition.
This acquisition strengthened the company’s respiratory diagnostics capabilities and expanded its presence across emerging healthcare markets worldwide

Key Findings of the Study

• Spirometers and spirometry tests dominate the global market
• Hospitals remain the leading end-user segment
• Rising respiratory disease prevalence is the primary growth driver
• North America leads the market, while Asia-Pacific shows fastest growth

More Info:- https://introspectivemarketresearch.com/reports/pulmonary-function-testing-systems-market/

About Us

At Introspective Market Research Private Limited, we are a forward-thinking research consulting firm committed to driving growth in the Pulmonary Function Testing Systems Market. With deep insights, strategic solutions, and holistic research, we empower businesses to achieve success and dominance in the global Pulmonary Function Testing Systems industry.

📞 Contact Us

Introspective Market Research Pvt. Ltd.
📞 Phone: +91-91753-37569
✉️ Email: sales@introspectivemarketresearch.com
🌐 Web: www.introspectivemarketresearch.com